GeneDx Corp (WGS): Projected Future Earnings

Public company logo of GeneDx Holdings (WGS)

GeneDx Holdings Corp. (WGS) future profit projections demonstrate the potential of high-yield whole-genome sequencing, which has become the benchmark for infant diagnostics. 0.04 serves as the current parameter value, reflecting market expectations. The business strives for leadership in exome analysis by leveraging AI for data decryption. Margin growth is driven by the accumulated array of genetic information, which accelerates the processing of new tests.

WGS - genedx.com Net Profit Forecast over the range 08/01/2024 - 11/18/2026

GeneDx Corp - analytical breakdowns and key metrics (WGS)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental company analysis:WGS, GeneDx
Finished products of Sema4

To minimize risks when establishing a long-term position, it is necessary to evaluate the asset's fundamental margin of safety through expected net income. By analyzing the projected profit dynamics, an investor can see the monetization of the unique genomic data array of GeneDx Holdings Corp. (WGS), which confirms the resilience of the business model of this genetic diagnostics leader and guarantees a stable cash flow from the multi-year utilization of the database by clinics and scientists.

Key competitors

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|ultragenyx.com - Projected Future Earnings|Beam Therapeutics - Future Net Profit|SRPT: Projected Future Earnings|TWST (Twist Bio) - Expected Profit|TXG (10xgenomics.com) - Projected Future Earnings|Projected Future Earnings Intellia Therapeutics, Inc.|Projected Future Earnings STOK|Company Profit Forecast BioLife Solutions Inc|Expected Profit Wave Pharma WVE|Projected Future Earnings Maze Therapeutics Corp MAZE|SION - Expected Profit|Prime Medicine, Inc. (PRME) - Future Profit|TSHA (Taysha Gene Therapies, Inc.) - Future Profit|QURE - Company Profit Forecast|MGTX (MeiraGTx Holdings plc) - Projected Future Earnings|Future Profit REGENXBIO Inc. (RGNX)|Expected Profit Solid Biosciences (SLDB)|ocugen.com (OCGN) - Projected Net Profit|Projected Future Earnings PACB (PacBio Corp)|Expected Net Income BNTC|DSGN: Future Profit|RCKT - Projected Future Earnings|Expected Net Income 4D Molecular Corp FDMT|Future Profit Lexeo|Expected Profit Korro Bio Inc.|Net Profit Forecast EDIT (Editas Medicine)|Expected Profit Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Expected Net Income|Projected Future Earnings CDXS (Codexis, Inc.)|Company Profit Forecast sangamo.com (SGMO)|nautilus.bio - Projected Future Earnings|Metagenomi (MGX) - Future Profit|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings